Position in IDYA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$5,392,406
-$322,807 QoQ
Shares Held
161,837
-2.1% QoQ
Ownership
0.184%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 99.78064348696527.ToString("F0")%
Shared 0.ToString("F0")%
None 0.21935651303472012.ToString("F0")%
Common Shares in IDYA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026ROYAL BANK OF CANADA holds $1,974,352,961 across 412 Biotechnology names. IDYA ranks #25 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,111,871 | $496,494,870 | |
| 2 | IONS |
Ionis Pharmaceuticals Inc
|
3,801,815 | $285,478,282 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
351,171 | $271,328,756 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
791,515 | $261,888,563 | |
| 5 | INCY |
Incyte Corp
|
1,054,123 | $99,214,053 | |
| 6 | INSM |
INSMED Inc
|
523,101 | $85,537,473 | |
| 7 | MRNA |
Moderna, Inc.
|
999,340 | $50,766,470 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
658,290 | $42,545,279 |
All Filings in IDYA
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,392,406 | 161,837 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $5,715,213 | 165,323 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $11,145,729 | 409,619 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $7,940,764 | 377,772 | Shares | Defined | 2025-11-21 | |
| 2025-03-31 | $2,005,892 | 122,460 | Shares | Defined | 2025-11-21 | |
| 2024-12-31 | $2,419,346 | 94,138 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $2,597,091 | 81,979 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $3,176,822 | 90,482 | Shares | Defined | 2024-11-06 | |
| 2024-03-31 | $2,357,407 | 53,724 | Shares | Defined | 2024-11-05 | |
| 2023-12-31 | $654,385 | 18,392 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $211,387 | 7,835 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $103,541 | 4,406 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $373,894 | 27,232 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $487,626 | 26,837 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $6,743 | 452 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $8,556 | 620 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $22,748 | 2,033 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $156,211 | 6,608 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $89,826 | 3,524 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $40,488 | 1,929 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $39,809 | 1,694 | Shares | Defined | 2021-07-20 | |
| 2020-12-31 | $14,896 | 1,064 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $301 | 24 | Shares | Defined | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||